This woman is suspected of dying of the Ebola virus in Liberia, but a local burial team is still forced to spray disinfectant over her in a desperate attempt to stop the disease spreading even further.
Now, officials in the country face a difficult choice of deciding which handful of Ebola patients will receive an experimental drug that could prove life-saving, ineffective or even harmful.
ZMapp, the untested Ebola drug, arrived in the West African country late on Wednesday. A day later, no one had yet received the treatment, which officials said would go to three people.